Keros Therapeutics, Inc.Keros Therapeutics, Inc.Keros Therapeutics, Inc.

Keros Therapeutics, Inc.

No trades
See on Supercharts

Price target

88.000.00 0.00%
The 9 analysts offering 1 year price forecasts for KROS have a max estimate of — and a min estimate of —.

Analyst rating

Based on 10 analysts giving stock ratings to KROS in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

KROS EPS for the last quarter is −1.34 USD despite the estimation of −1.37 USD. In the next quarter EPS is expected to reach −1.33 USD. Track more of Keros Therapeutics, Inc. financials and stay on top of what is up with the company.
According to analysts, KROS price target is 88.00 USD with a max estimate of 105.00 USD and a min estimate of 77.00 USD. Check if this forecast comes true in a year, meanwhile watch Keros Therapeutics, Inc. stock price chart and keep track of the current situation with KROS news and stock market news.
We've gathered opinions of 10 analysts rating KROS stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.